Posted by Michael Wonder on 15 Dec 2022
Trifluridine with tipiracil hydrochloride for the treatment of patients with metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after two or more treatments
14 December 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use of trifluridine with tipiracil hydrochloride in the NHS in England.
Trifluridine with tipiracil hydrochloride is recommended as an option for the treatment of adults with metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma who have had two or more treatment regimens.
